Prospective Grant of Co-Exclusive License: “Endotracheal Tube Using Leak Hole To Lower Resistance and Dead Space”

Riepilogo

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a co-exclusive license worldwide to practice the inventions embodied in: U.S. Application No. 09/967,903, filed September 28, 2001, entitled "Endotracheal Tube Using Leak Hole to Lower Resistance and Dead Space" to Vital Signs, Inc. of Totowa, New Jersey. The United States of America is the assignee to the patent rights of these inventions. The field of use of the contemplated co-exclusive license may include all medical applications, and the other co- exclusive licensee has not yet been identified.